Stromelysin 2

Stromelysin 2, also known by its scientific name MMP-10 (Matrix Metalloproteinase-10), is an enzyme that plays a crucial role in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. This enzyme belongs to the matrix metalloproteinase (MMP) family, a group of proteolytic enzymes involved in the degradation of extracellular matrix components.

Function

Stromelysin 2 is involved in the breakdown of extracellular matrix in normal physiological processes such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes. It is capable of degrading a variety of matrix components, including but not limited to, collagen, gelatin, and fibronectin. This wide range of substrate specificity allows MMP-10 to play a significant role in tissue remodeling and repair processes. Additionally, MMP-10 is implicated in various pathological conditions, including inflammatory diseases, cancer, and fibrosis, by facilitating the invasion of cancer cells and the migration of inflammatory cells.

Gene and Expression

The gene encoding MMP-10 is located on chromosome 11q22.3. Its expression is tightly regulated at the transcriptional level and is induced by various stimuli, including inflammatory cytokines, growth factors, and cellular stress. MMP-10 is expressed in a variety of tissues and cell types, including fibroblasts, macrophages, and endothelial cells. The regulation of MMP-10 expression is crucial for maintaining tissue homeostasis and its dysregulation can lead to pathological conditions.

Clinical Significance

Alterations in the expression and activity of MMP-10 have been associated with a number of diseases. In the context of cancer, MMP-10 is thought to contribute to tumor progression and metastasis by degrading extracellular matrix components, thereby facilitating the invasion of tumor cells into surrounding tissues and blood vessels. In inflammatory diseases, such as rheumatoid arthritis, MMP-10 is involved in the destruction of joint cartilage and bone. Therefore, MMP-10 is considered a potential therapeutic target, and inhibitors of MMP-10 are being explored as treatment options for various diseases.

Research and Therapeutic Approaches

Research on MMP-10 has focused on understanding its role in disease processes and developing inhibitors that can specifically target this enzyme. Several small molecule inhibitors and antibody-based therapies are under investigation for their potential to inhibit MMP-10 activity. These therapeutic approaches aim to prevent the degradation of the extracellular matrix, thereby inhibiting tumor progression, metastasis, and tissue destruction in inflammatory diseases.

See Also

• Matrix metalloproteinase
• Extracellular matrix
• Cancer metastasis
• Inflammatory diseases

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian